Advertisement
Sunday, Nov 28, 2021
Outlook.com
Outlook.com

India To Resume Export Of Surplus Vaccines Next Month Under 'Vaccine Maitri'

Health Minister Mansukh Mandaviya said the government will receive over 30 crore doses of COVID-19 vaccines in October and over 100 crore doses in the next three months.

India To Resume Export Of Surplus Vaccines Next Month Under 'Vaccine Maitri'
Covid-19 vaccine | PTI/File Photo
India To Resume Export Of Surplus Vaccines Next Month Under 'Vaccine Maitri'
outlookindia.com
2021-09-20T17:06:30+05:30

With a decline of Covid-19 cases in the country, the health minister of Monday said that India will resume the export of surplus Covid-19 vaccines from October. Under the 'Vaccine Maitri' programme, India will start exporting vaccines to other countries to meet its commitment to the COVAX global pool. However, Union Health Minister Mansukh Mandaviya insisted that the vaccination of Indians was going to remain the top priority.

The government is set to receive over 30 crore doses of COVID-19 vaccines in October and over 100 crore doses in the next three months, Mandaviya said.

He also said that cumulative doses administered so far across the country have crossed 81 crore and the last 10 crore doses were administered in only 11 days.

Asserting that vaccination of our own citizens remains the government's topmost priority, Mandaviya said the export of surplus vaccines would begin in the next quarter (October-December) under the Vaccine Maitri programme and in order to fulfill the commitment of India towards COVAX. 

This is in line with our motto of 'Vasudhaiva Kutumbakam', he said. 

He said that the surplus supply of vaccines will be used to fulfill India's commitment towards the world for the collective fight against Covid-19.

COVAX is co-led by Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and WHO.

Highlighting the importance of indigenous research and production of Covid vaccines in India, he said that it is due to the relentless efforts and guidance of Prime Minister Narendra Modi that India was simultaneously undertaking research and production of Covid vaccines in such a big way.

India's vaccination drive has been a role model for the world and it is marching ahead with great speed, he said. 

Talking about the expected production and supply trends in the coming months, he said that more than 30 crore doses will be produced in October and more than 100 crores in the coming quarter.

(With inputs from PTI)

Advertisement

Outlook Newsletters

Advertisement
Advertisement
Advertisement

Read More from Outlook

Omicron: New Strain Of Coronavirus Escalates Need For Global Vaccine Sharing

Omicron: New Strain Of Coronavirus Escalates Need For Global Vaccine Sharing

'Despite the repeated warnings of health leaders, our failure to put vaccines into the arms of people in the developing world is now coming back to haunt us', wrote former British PM Gordon Brown.

Covid-19: Experts' Take On Omicron And Possibility Of Third Wave In India

Covid-19: Experts' Take On Omicron And Possibility Of Third Wave In India

Though the health experts and scientists in India have advised caution yet they feel that the current immune profile of the majority of the population in India makes them less vulnerable to Omicron as compared to any other country in the world.

Iyer Plays Down Record, Says 'Important Thing Is To Win Match'

Iyer Plays Down Record, Says 'Important Thing Is To Win Match'

Shreyas Iyer hit 105 and 65 against New Zealand to become the first Indian batter to score a century and half-century in his debut Test match.

What Is Omicron: All You Need To Know About The New Coronavirus Strain

What Is Omicron: All You Need To Know About The New Coronavirus Strain

After the detrimental Delta variant which took the world by storm in the second wave of Covid-19, WHO recently declared ‘Omicron’ as the latest ‘variant of concern’ (VOC).

Advertisement